AYTU BIOPHARMA INC - COM NEW (AYTU)

CUSIP: 054754874

Q1 2023 13F Holders as of 31 Mar 2023

Share change
-8,028,675
SEC-reported price per share
$0.18
Number of holders
1
Value change
-$1,517,395
Number of sells
29

Security key

054754874

Report period

Q1 2023

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of AYTU - AYTU BIOPHARMA INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $5,017,808 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $5.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
ARMISTICE CAPITAL, LLC $5.02M
RENAISSANCE TECHNOLOGIES LLC $405K
Gary Cantrell $306.7K
Alyeska Investment Group, L.P. $283.5K
MILLENNIUM MANAGEMENT LLC $225K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
3/4/5
Director
—
denominator unverified
$5,017,808
2,684,756 shares
— 20 Mar 2021
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$405,000
2,140,782 shares
— 31 Dec 2022
Gary Cantrell
3/4/5
Director
—
denominator unverified
$306,682
164,089 shares
— 21 Dec 2022
Alyeska Investment Group, L.P.
13F
Company
13F
—
denominator unverified
$283,500
1,500,000 shares
— 31 Dec 2022
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$225,000
1,189,958 shares
— 31 Dec 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$183,979
973,435 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
5,579
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
1
Q1 2023 holders
1
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .